
Qubit Pharmaceuticals is a drug discovery company that utilizes quantum physics and artificial intelligence to design novel drug candidates for major diseases. Their proprietary ATLAS platform,…

Qubit Pharmaceuticals is a drug discovery company that utilizes quantum physics and artificial intelligence to design novel drug candidates for major diseases. Their proprietary ATLAS platform,…
Founded: 2020
Headquarters: Paris, France
Focus: Quantum-aided drug discovery (oncology, inflammation, pandemic response)
Proprietary platform: ATLAS — quantum physics + AI molecular simulation
Team size: ~60 employees
Notable investors: Includes European Innovation Council and Omnes Capital
Drug discovery for major diseases with emphasis on oncology, inflammation, and pandemic response.
2020
Biotechnology
European Innovation Council grant
Seed round reported with five investors (named investors include Omnes Capital and European Innovation Council)
“Includes institutional and public innovation investors (European Innovation Council, Omnes Capital) and multiple seed-stage backers”
Qubit Pharmaceuticals is a French-American deeptech startup, focusing on discovering novel molecules for complex targets in healthcare and materials science. We leverage proprietary molecular simulation and quantum-physics based modeling technology to develop our own discovery programs that we either co-develop with or license out to pharmaceutical and industrial partners. This enables us to design more effective and safer drug candidates, aiming to significantly reduce the time and investment needed for discovery. In just 18 months, Qubit Pharmaceuticals grew its portfolio to 7 programs in oncology, immunology & antivirals.
Our cutting-edge technology is based on over 30 years of research by our academic founders, and relies on three main components: in-depth expertise in computational science and high-performance computing (HPC), quantum chemistry and artificial intelligence algorithms, and a powerful, automated cloud platform for molecular simulation with chemical accuracy. We recently announced the launch of the world's most powerful AI foundation model for molecular simulation.
Qubit Pharmaceuticals is looking for a Senior Machine Learning and Quantum Chemistry Scientist to lead the development of foundation models for chemistry
At Qubit Pharmaceuticals, we are looking for a Senior Machine Learning and Quantum Chemistry Scientist who is quick at adapting to new challenges and issues. This person will be eager to learn, meet the needs of users, and work in a collaborative process with teammates and across multiple teams.
As a member of the Research team, you will be responsible for the Quantum Chemistry Foundation Model development, including molecules quantum datasets selection, model training, coding, testing and validation.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week
Master degree or equivalent in Applied Maths / Computer Science / Chemistry
PhD in Quantum Chemistry and Machine learning is strongly preferred
Minimum of 5 years work experience (including PhD) is required
Knowledge of quantum chemistry is strongly preferred
Proficiency in active learning, architecture, and training methods, related to Machine Learning Force Field, Machine Learning Interaction Potentials, Neural Networks Potentials
Ability to motivate and lead a project team
Excellent communication skills for explaining complex concepts to non-specialists
Agility in a startup environment (changing priorities, multiple projects)
Open-source code development and maintenance is valuable